333
Views
8
CrossRef citations to date
0
Altmetric
Original Articles

Cytotoxicity of Resorcinol Under Short- and Long-Term Exposure in Vitro

&
Pages 147-156 | Published online: 08 Jan 2015

References

  • Seibert H, Gulden M, Kolossa M, Schepers G. Evaluation of the relevance of selected in vitro toxicity test systems for acute systemic toxicity. ATLA 1992;20:240–5.
  • Balls M, Fentem JH. The use of basal cytotoxicity and target organ toxicity tests in hazard identification and risk assessment. ATLA 1992;20:386–8.
  • Seibert H, Gulden M, Voss J-U. Comparative cell toxicology: the basis for in vitro toxicity testing. ATLA 1994;22:168–74.
  • American Conference of Governmental Industrial Hygienists (ACGIH). Documentation of the TLVs® and BEIs® with other worldwide occupational exposure values [CD-ROM]. Cincinnati, OH, USA: ACGIH; 2002.
  • TOXLINE®, CCINFOdisc. [CD-ROM]. Hamilton Ont., Canada: Canadian Centre for Occupational Health and Safety, 2002.
  • Sapota A, Ligocka D. Rezorcyna. Principles and Methods of Assessing the Working Environment 2001;1(27):127–45.
  • Tennant JA. Evaluation of trypan blue technique for determination of cell viability. Transplantation 1964;12:285–692.
  • Ekwall B. Correlation between cytotoxicity in vitro and LD50 values. Acta Pharmacol Toxicol (Copenh) 1983;52(Suppl. II):80–99.
  • INVITTOX protocol No. 64. The neutral red cytotoxicity assay. The ERGATT/FRAME data bank of in vitro techniques in toxicology. Nottingham, UK: INVITTOX; 1992.
  • INVITTOX protocol No. 17. MTT assay. The ERGATT/FRAME data bank of in vitro techniques in toxicology. Nottingham, UK: INVITTOX; 1990.
  • INVITTOX protocol No. 3b. The frame cytotoxicity test (kenacid blue). The ERGATT/FRAME data bank of in vitro techniques in toxicology. Nottingham, UK: INVITTOX; 1992.
  • Hockley K, Baxter D. Use of the 3T3 cell-neutral red uptake assay for irritants as an alternative to the rabbit (Draize) test. Fd Chem Toxic 1986;24(6/7):473–5.
  • Knox P, Uphill PF, Fry JR, Benford J, Balls M. The FRAME multicentre project on in vitro cytotoxicology. Fd Chem Toxic 1986;24:457–63.
  • Zapór L. Toxicity of some phenolic derivatives一invitro studies. JOSE. Inpress.
  • Burch W, Ellinger A, Torok L, Parzafall W, Coulibaly S, Hochegger K, Schorkhuber M, Patrik G, Marian B, Walker R, Sikorska R, Schulte-Hermann L. In Vitro studies on subtypes and regulation of active cell death. Toxicol in Vitro 1997;11:579–88.
  • Cornelis M, Dupont C, Wepierre J. In vitro cytotoxicity tests on cultured human skin fibroblasts to predict the irritation potential of surfactants. ATLA 1991;19(3):324–36.
  • Davila JC, Rodriquez RJ, Melchert RB, Acosta D. Predictive value of in vitro model systems in toxicology. Annu Rev Pharmacol Toxicol 1998;63–96
  • Jain PT, Fitzpatrick MJ, Phelps PC, Berezesky IK, Trump BF. Studies of skin toxicity in vitro: dose-response studies on JB6 cells. Toxicol Pathol 1992;20:394–404.
  • Ruppova K, Urbancikova M, Wsolowa L, SlamenovaD. Apoptosis versus cytotoxicity in HeLa cells exposed to paracetamol. ATLA 1999;27(3):403–12.
  • Clothier RH, Hulme L, Ahmed AB, Reeves HL, Smith M, Balls M. In vitro cytotoxicity of 150 chemicals to 3T3-L1 cells, assessed by the FRAME kenacid blue method. ATLA 1988;16:84–95.
  • Riddell RJ, PanacerDS. Wilde SM, Clothier RH, Balls M. The importance of exposure period and cell type in in vitro cytotoxicity tests.ATLA 1986;14:86–92.
  • Frazier JM. Multiple endpoint measurements to evaluate the intrinsic cellular toxicity of chemicals. In Vitro 1990;3:349.
  • Halle W, Spielmann H. Two procedures for the prediction of acute toxicity (LD50) from cytotoxicity data. ATLA 1992;20(1):40–9.
  • Shaw AJ. Defining cell viability and cytotoxicity. ATLA 1994;22(2):124–6.
  • Borenfreund E, Babich H, Martin-Alguacil N. (1990). Comparison of two in vitro cytotoxicity assays: the neutral red (NRU) and tetrazolium MTT tests. Toxicol in Vitro 1990;2:1–6
  • Walum E, Balls M, Bianchi V, Blaauboer B, Bolcsfoldi G, Guillouzo A, Moore GA, Odland L, Reinhardt Ch, Spielmann H. ECITTS: An integrated approach to the application of in vitro test systems to the hazard assessment of chemicals. ATLA 1992;20:406–28.
  • Chiba K, Kawakami K, Tohyama K. Simultaneous evaluation of cell viability by neutral red, MTT and crystal violet staining assays of the same cells. Toxicol in Vitro 1998;12:251–8.
  • Vian L, Vincent J, Maurin J, Fabre I, Giroux J, Cano JP. Comparison of three cytotoxicity assays for estimating surfactant ocular irritation. Toxicol in Vitro 1995;9:185–90.
  • Waterfield CJ, Delaney J, Kerai MDJ, Timbrell JA. Correlation between in vivo and in vitro effects of toxic compounds: studies with hydrazine. Toxicol in Vitro 1997;11:217–27.
  • Clothier RH, Atkinson KA, Garle MJ, Ward RK, Willshaw A. The development and evaluation of in vitro tests by the FRAME Alternatives Laboratory. ATLA 1995;23:75–90.
  • Combes RD. Summary of discussion: in vitro models for investigation of chronic toxicity and reversibility. Toxicol in Vitro 1999;13:853–7.
  • Hanley AB, McBride J, Oehlschlager S, Opara E. Use of flow cell bioreactor as a chronic toxicity model system. Toxicol in Vitro 1999;13:847–51.
  • Skowroń J, Zapór L. Ocena działania cytotoksycznego chlorku benzalkonium w warunkach narażenia długotrwalego in vitro w bioreaktorze INTEGRA CL 6-WELL. Bromatologia i Chemia Toksykologiczna 2002;XXXV(2):179–85.
  • Calabrese EJ, Baldwin LA. Hormesis: a generalizable and unifying hypothesis. Crit Rev Toxicol 2001;31(4/5):353–425.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.